These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38672465)

  • 21. Cost analysis of total neoadjuvant therapy with 5 × 5 Gy radiation therapy versus conventional chemoradiotherapy for locally advanced rectal cancer among Peruvians.
    Díaz JFR; Changra HO
    Ecancermedicalscience; 2022; 16():1406. PubMed ID: 36072238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.
    Xu T; Feng L; Zhang W; Li H; Ma H; Abulimiti M; Tan Y; Deng F; Huang W; Zou S; Kang W; Jiang L; Wang Y; Hu C; Chen Y; Zhou H; Tang Y; Jin J
    BMC Cancer; 2024 Apr; 24(1):501. PubMed ID: 38641773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer.
    Yang G; Chang JS; Choi JE; Baek ES; Kim SS; Byun HK; Cho Y; Koom WS; Yang SY; Min BS; Shin SJ
    Radiat Oncol; 2022 May; 17(1):100. PubMed ID: 35597954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis.
    Liu SX; Zhou ZR; Chen LX; Yang YJ; Hu ZD; Zhang TS
    Asian Pac J Cancer Prev; 2015; 16(14):5755-62. PubMed ID: 26320447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
    Hoendervangers S; Sparreboom CL; Intven MPW; Lange JF; Verkooijen HM; Doornebosch PG; van Grevenstein WMU;
    Eur J Surg Oncol; 2020 Sep; 46(9):1605-1612. PubMed ID: 32192792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Short-course radiotherapy combined with CAPOX and PD-1 inhibitor for the total neoadjuvant therapy of locally advanced rectal cancer: the preliminary single-center findings of a prospective, multicentre, randomized phase II trial (TORCH)].
    Wang YQ; Shen LJ; Wan JF; Zhang H; Wang Y; Wu X; Wang JW; Wang RJ; Sun YQ; Tong T; Huang D; Wang L; Sheng WQ; Zhang X; Cai GX; Xu Y; Cai SJ; Zhang Z; Xia F
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):448-458. PubMed ID: 37217353
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.
    Chin RI; Otegbeye EE; Kang KH; Chang SH; McHenry S; Roy A; Chapman WC; Henke LE; Badiyan SN; Pedersen K; Tan BR; Glasgow SC; Mutch MG; Samson PP; Kim H
    JAMA Netw Open; 2022 Feb; 5(2):e2146312. PubMed ID: 35103791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort study.
    Couwenberg AM; Burbach JPM; Intven MPW; Consten ECJ; Schiphorst AHW; Smits AB; Wijffels NAT; Heikens JT; Koopman M; van Grevenstein WMU; Verkooijen HM
    Acta Oncol; 2019 Apr; 58(4):407-416. PubMed ID: 30656996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Donnelly M; Ryan OK; Ryan ÉJ; Creavin B; O'Reilly M; McDermott R; Kennelly R; Hanly A; Martin ST; Winter DC
    Br J Surg; 2023 Sep; 110(10):1316-1330. PubMed ID: 37330950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
    Jia AY; Narang A; Safar B; Zaheer A; Murphy A; Azad NS; Gearhart S; Fang S; Efron J; Warczynski T; Hacker-Prietz A; Meyer J
    Radiat Oncol; 2019 Aug; 14(1):147. PubMed ID: 31426827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of statin and aspirin use on toxicity and pathological complete response rate of neo-adjuvant chemoradiation for rectal cancer.
    Hardie C; Jung Y; Jameson M
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):167-73. PubMed ID: 26947944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer.
    Banwell VC; Phillips HA; Duff MJ; Speake D; McLean C; Williams LJ; He Y; Paterson HM
    Acta Oncol; 2019 Sep; 58(9):1267-1272. PubMed ID: 31237192
    [No Abstract]   [Full Text] [Related]  

  • 33. Real-World Use of Hypofractionated Radiotherapy for Primary CNS Tumors in the Elderly, and Implications on Medicare Spending.
    Tringale KR; Lin A; Miller AM; Khan A; Chen L; Zinovoy M; Yamada Y; Yu Y; Pike LRG; Imber BS
    J Natl Compr Canc Netw; 2024 Apr; 22(4):. PubMed ID: 38688308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer.
    Kaytan-Saglam E; Balik E; Saglam S; Akgün Z; Ibis K; Keskin M; Dagoglu N; Kapran Y; Gulluoglu M
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1597-1603. PubMed ID: 28374169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI demonstration of the effect of neoadjuvant radiotherapy on rectal carcinoma.
    Jacques AE; Rockall AG; Alijani M; Hughes J; Babar S; Aleong JA; Cottrill C; Dorudi S; Reznek RH
    Acta Oncol; 2007; 46(7):989-95. PubMed ID: 17851843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma.
    Yu ZQ; Zhang C; Wang H; Lao XY; Chai R; Gao XH; Cao GW; Fu CG
    Dis Colon Rectum; 2013 May; 56(5):600-8. PubMed ID: 23575399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
    Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
    Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions).
    Wang L; Zhong XG; Peng YF; Li ZW; Gu J
    Colorectal Dis; 2014 Jan; 16(1):33-9. PubMed ID: 23848511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between of short-course preoperative radiotherapy and serum albumin level and postoperative complications in rectal cancer surgery.
    Trifunović B; Kršić J; Bezmarević M; Grbović D; Zeljković D; Nešković B; Soldatović I; Prelević R; Mirković D
    Vojnosanit Pregl; 2015 Aug; 72(8):663-9. PubMed ID: 26495691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma.
    Farchoukh L; Hartman DJ; Ma C; Celebrezze J; Medich D; Bahary N; Frank M; Pantanowitz L; Pai RK
    Mod Pathol; 2021 Jan; 34(1):171-183. PubMed ID: 32661298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.